- Home
- IMUX vs MRT Comparison
IMUX vs MRT Comparison
Compare IMUX & MRT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | IMUX | MRT |
|---|---|---|
| Founded | 2016 | 2018 |
| Country | United States | Turkey |
| Employees | 66 | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Rental/Leasing Companies |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 152.6M | 159.0M |
| IPO Year | 2013 | 2021 |
Fundamental Metrics
Financial Performance| Metric | IMUX | MRT |
|---|---|---|
| Price | $1.18 | $2.12 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 5 | 2 |
| Target Price | $4.80 | ★ $6.00 |
| AVG Volume (30 Days) | ★ 1.8M | 14.2K |
| Earning Date | 05-14-2026 | 08-08-2018 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 38.00 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $84.47 |
| Revenue Next Year | N/A | $94.45 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.51 | $1.97 |
| 52 Week High | $1.51 | $3.70 |
Technical Indicators
Market Signals| Indicator | IMUX | MRT |
|---|---|---|
| Relative Strength Index (RSI) | 53.23 | 54.29 |
| Support Level | $1.05 | $1.98 |
| Resistance Level | $1.35 | $2.15 |
| Average True Range (ATR) | 0.11 | 0.04 |
| MACD | -0.01 | 0.01 |
| Stochastic Oscillator | 53.13 | 49.75 |
Price Performance
Historical ComparisonAbout IMUX Immunic Inc.
Immunic Inc is a clinical-stage biopharmaceutical company developing a pipeline of selective oral immunology therapies aimed at treating chronic inflammatory and autoimmune diseases, including ulcerative colitis, Crohn's disease, relapsing-remitting multiple sclerosis, and psoriasis. The company is developing small molecule products, which include IMU-838, which is a selective immune modulator that inhibits the intracellular metabolism of activated immune cells by blocking the enzyme DHODH; IMU-935 is an inverse agonist of RORyt, and IMU-856 targets the restoration of the intestinal barrier function. It operates in one segment which is Life science segment.
About MRT Marti Technologies Inc.
Marti Technologies Inc is a mobility app, offering multiple transportation services to its riders. Marti operates a ride-hailing service that matches riders with car, motorcycle, and taxi drivers, and operates a large fleet of rental e-mopeds, e-bikes, and e-scooters. All of Marti's offerings are serviced by proprietary software systems and IoT infrastructure.